SUBSCRIBE: Print / eNewsletter
Getting to Transplant Remains Goal in Relapsed/Refractory Hodgkin Lymphoma
As part of our coverage of the ASH Annual Meeting, we are discussing novel agents and strategies for relapsed/refractory Hodgkin lymphoma.
Jennifer Ligibel Discusses New Data Strengthening the Link Between Obesity and Cancer
In this interview we discuss a recent report from the International Agency for Research on Cancer that evaluated the evidence linking obesity to cancer risk.
Can Schools Play Role in Skin Cancer Prevention?
In this interview we discuss the idea of using schools to increase knowledge about skin cancer and attitudes toward sun exposure.
Supportive Care for T-Cell Lymphomas
In this interview we discuss the different types of T-cell lymphomas and how supportive care is used in the management of these malignancies.
Update on the Management of Myeloproliferative Neoplasms
In this interview we discuss symptoms and prognosis for patients with polycythemia vera and essential thrombocythemia and the treatment of myelofibrosis.
Could Gene Assay Help Guide Stage II Colon Cancer Treatment?
In this interview we discuss the GeneFx Colon test (or the ColDx assay), which can helpful identify patients with low- or high-risk stage II colon cancer.
New Consensus Guidelines on DCIS Establish Ideal Surgical Margins
In this interview we discuss new consensus guidelines from ASCO, SSO, and ASTRO that establish 2 mm surgical margins for treating DCIS patients.
Finding the Mechanisms of Immunotherapy Resistance
In this interview we discuss a recent study that identified genetic mechanisms of immunoresistance to treatment with anti-PD-1 antibodies.
Latest Immunotherapy Research in Treating Colorectal Cancer
In this interview we discuss the CheckMate 142 trial, which looked at nivolumab and ipilimumab for the treatment of metastatic colorectal cancer.
Follow-Up Care and Screening for Cancer Survivors
In this interview we discuss follow-up care and screening for second primary cancers in cancer survivors.